Study on HIV prevention for people who inject drugs
Part of Infections clinical trials.
This study tests different ways to help people who inject drugs stay on PrEP, a daily pill that prevents HIV. It's for people who are HIV-negative and have recently injected drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have injected drugs at least once in the past month.
- You have used a syringe service program (a place where you can get clean needles) in the past 30 days.
- You are willing to take part in multiple counseling sessions and follow-up visits.
- A doctor has said you might benefit from PrEP in the last 6 months (based on CDC guidelines).
- You are HIV-negative and not already taking PrEP.
- You do not have severe kidney problems or a chronic hepatitis B infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether telehealth support can help people who inject drugs start and stay on PrEP (HIV prevention medicine). You will join several sessions and follow-up visits to see if this approach works better than standard care.
This study looks at using social connections to help people who inject drugs get HIV prevention and substance use support. The trial tests a program in Los Angeles that works with friends or peers to encourage PrEP (HIV prevention pills) and addiction treatment.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
This trial looks at how well a daily HIV-prevention pill (F/TAF) works in people who use drugs. The goal is to understand real-world effectiveness and help support people in staying HIV-negative.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.